In addition, expression of CXCL8, CCL2, CXCL10, and CCL20 was also increased in prostate cancer tissue induced by intraprostatic injection of LNCaP cells stably transfected with SFMBT2 shRNA and in the tissue of prostate cancer patients. The gene discussed is CCL20; the disease is prostate cancer.